Leigh was Chief Scientific Officer, Small Molecules at Cullinan Oncology, and Executive Partner at MPM BioImpact. Leigh Zawel joined Pheon Therapeutics in 2022.
Leigh Zawel is currently
Create your alert
to follow the career of Leigh Zawel.
In 1995, Leigh Zawel completed a PhD in Biochemistry at University of Medicine and Dentistry of New Jersey.
Do you need to know more about Leigh Zawel? More results.
Report an error
Update the org chart details of Leigh Zawel.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.